Pharma
SPAC To Merge With SPAC That Merged With Spinoff From Company The First SPAC Is Merging With
This may be the first SPAC to essentially merge with itself, but it will most assuredly not be the last.
Prison No Reason For Martin Shkreli To Let His Anticompetitive Guard Down
If he’s got to do seven years for jacking up a drug’s price, he’s gonna make damned sure it stays jacked up.
You’re Not Going To Believe This, But Vaccine Execs Sold A Lot More Stock Last Year Than The Year Before
Those 10b5-1 sales sure were preset perfectly for a pandemic.
Pharma Looking Back Fondly On Days When It Was Only Accused Of Misusing Charities To Prop Up Drug Prices
You know, those halcyon days of last week.
Opioid Dealer’s Charity Allegedly A Front For Jacking Up Price Of Other Drug
Oh, there was also some alleged insurance fraud going on in the opioid-pushing.
Congressman Pleading Guilty To Insider Trading Somehow Avoids Getting Two-Year SEC Ban From Doing Congress
Rep. Chris Collins should have just started a hedge fund.
In Legal Terms, Martin Shkreli Is Still Guilty AF
The Second Circuit Court of Appeals would like The Shkrelster to just finish up that prison sentence in silence.
Denmark’s Genmab files for $500M Nasdaq listing in US
The company, whose FDA-approved products include the myeloma drug Darzalex and the chronic leukemia drug Arzerra, hopes to launch its own proprietary product by 2025.
Of Course The College Bribery Scandal Came To Light Via A Bungled Pharma Pump And Dump Scheme...And Yale
We can taste this one it's so perfect.
Martin Shkreli "Didn't" Call The WSJ From Prison To Remind Everyone That He Is Still Doing Crimes
Giving a thinly-veiled anonymous interview on a contraband cellphone to brag about how he is illegally running a pharma business from prison reminds us why we miss this guy.
Seattle Shrink Admits That Therapy Sessions Might Not Be Best Place For Legal Stock Tips
This even applies to pharma apparently.
Wilson Sonsini tops Life Sciences Law Firm Index for 2nd straight year
The Life Sciences Law Firm Index identifies the most active and relevant firms for life science companies.
The Trump Inc ETF: A Dealbreaker Exclusive
Trump's vast array of conflicts of interest provide a profit opportunity for the savvy investor.
Proposed Professionalization Of Valuation Analysis Poses An Existential Threat To Valeant
How do you put a price on failure?
Dystopian Trump Portfolio Taking Shape Nicely
Weapons manufacturers and private prisons are loving this whole Trump thing today.
Valeant Can’t Even Sell Female Orgasms: Lawsuit
Although this could give someone an idea about how to fix Chipotle.
Valeant To Stop Profiting From Ulcers It’s Giving Shareholders
Fun with pharma stocks and irony!
Price-Gouging Mylan CEO Doesn't Need Real MBA To Know When To Dump Her Own Stock
Heather Bresch seems to have known that Heather Bresch's management was going to have an adverse effect on Mylan stock.
Martin Shkreli Can't Stop Getting Charged By The Feds
That brings Martin's grand total to eight...so far.